##plugins.themes.academic_pro.article.main##

Abstract

The investigation into the involvement of vitamin D in the pathogenesis and prevention of type 2 diabetes has garnered widespread scholarly attention. Notably, vitamin D receptors are discernible in pancreatic beta cells and immune cells. In addition to its established function as the primary regulator of calcium absorption, vitamin D exerts influence on the activity of calcium-associated endopeptidases in beta cells, facilitating the conversion of proinsulin to insulin and augmenting insulin production. Within peripheral insulin target tissues, vitamin D governs insulin action through the modulation of calcium homeostasis. Further, vitamin D exhibits pronounced immunosuppressive properties. Noteworthy is the potential implication of vitamin D deficiency in the etiology of type 2 diabetes, manifesting in the inhibition of insulin secretion and enhancement of glucose tolerance. The article underscores the imperative for comprehensive research and clinical trials elucidating the multifaceted roles of vitamin D and calcium in maintaining a robust physiological framework. Insightful findings from studies conducted in Uzbekistan and globally underscore a prevailing inadequacy in the dietary intake of calcium and vitamin D among diverse populations, taking into account geographical, ethnic, and physiological variances. Emphasis is placed on the critical significance of sustaining optimal levels of calcium and vitamin D for skeletal health, particularly in the context of osteoporosis prevention and treatment.

Keywords

Vitamin D calcium type 2 diabetes

##plugins.themes.academic_pro.article.details##

How to Cite
M.R. Umarova. (2023). The Importance of Vitamin D And Calcium in Type 2 Diabetes. Texas Journal of Medical Science, 27, 64–67. https://doi.org/10.62480/tjms.2023.vol27.pp64-67

References

  1. Angel B., Santos J.L., Carrasco E., Albala C., Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur J Epidemiol 2014; 19(12):1085-1087.
  2. Carmeliet G., Dermauw V., Bouillon R. Vitamin D signaling in calcium and bone homeostasis: A delicate balance. Best Practice & Research Clinical Endocrinology & Metabolism. 2015; 29(4): 621-631.
  3. Clinical recommendations for the treatment of type 2 diabetes. National Association of Endocrinologists of Uzbekistan, 2019. 132 p.
  4. Dawson-Hughes B. The role of calcium in bone growth and preservation. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Non-sponsored Symposia Abstracts. Osteoporos Int. 2017; 28(S1):99-126.
  5. de Assumpção D., Dias MRMG, de Azevedo Barros M.B., et al. Calcium intake by adolescents: a population-based health survey. J. Pediatr (Rio J). 2016; 92(3): 251-259.
  6. Hagenau T., Vest R., Gissel T.N., et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2018; 20(1): 133-140
  7. https://www.idf.org – Endocrinological and Diabetes Association of Uzbekistan [10.12.2023]
  8. IDF Diabetes Atlas 10 th edition. International Diabetes Federation. 2022.
  9. Ismoilov S.I. Selected lectures from endocrinology [Endokrinologiyadan tanlangan ma’ruzalar]. – Tashkent, 2005. – P. 105-183.
  10. Janssen H.C., Samson M.M., Verhaar H.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002; 75(4): 611-615.
  11. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005; 48(7): 1247-1257.
  12. Ogunkolade B.W., Boucher B.J., Prahl J.M., Bustin S.A., Burrin J.M., Noonan K., North B.V., et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002; 51(7): 2294-2300.
  13. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin Endocrinol Metab 2007; 92(6): 2017-2029.
  14. Reis A.F., Hauache O.M., Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab 2005; 31(4 Pt 1): 318-325.
  15. Shagazatova B.Kh. Endocrinology [Endokrinologiya: darslik]. – Toshkent: Ijod-Print Co., 2020. 490 pp.
  16. Sicree R., Shaw J., Zimmet P. Prevalence and projections. In: Diabetes Atlas 3rd ed. Brussels, Belgium: International Diabetes Federation, 2006:16-104.
  17. Speer G., Cseh K., Winkler G., Vargha P., Braun E., Takacs I., Lakatos P. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 2001; 144(4): 385-389.
  18. Tuorkey M.J., Abdul-Aziz K.K. Strategies for diabetes and pathways of vitamin D. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2010; 4(2):101-110.
  19. Wilczynski C., Camacho P. Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies. Current Osteoporosis Reports. 2014; 12(4):396-402.

Similar Articles

You may also start an advanced similarity search for this article.